Company Profiles

driven by the PitchBook Platform

Accelalox

Description

Owner and operator of a biotechnology and pharmaceutical company. The company develops therapies to treat muscle and bone conditions focusing on oral and small-molecule therapy.

2005

Founded

PRIVATE

Status

Grant

Latest Deal Type

$229k

Latest Deal Amount

$430k

Total Amount Raised

1

Investors

Description

Owner and operator of a biotechnology and pharmaceutical company. The company develops therapies to treat muscle and bone conditions focusing on oral and small-molecule therapy.

Website:

www.accelalox.com

Ownership Status

Privately Held (backing)

Financing Status

Angel-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Other Industries

Other Healthcare

Primary Office

325 Sharon Park Drive Suite 310 Menlo Park, CA 94025United States +1 (650) 854-1465
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Accelalox's full profile, request a free trial.

    Accelalox Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Accelalox Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    U.S. Department of Health and Human ServicesGovernment000 0000000 0000
    U.S. Department of Health and Human Services Government

    Accelalox Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Julia O'ConnorCo-Founder & Chief Executive Officer
    J. Patrick O'Connor Ph.DCo-Founder, Board Member, Chairman of Scientific Advisory Board & Chief Scientific Officer
    Julia O'Connor Co-Founder & Chief Executive Officer
    J. Patrick O'Connor Ph.D Co-Founder, Board Member, Chairman of Scientific Advisory Board & Chief Scientific Officer
    Request full access to PitchBook